Federal Register / Vol. 82, No. 154 / Friday, August 11, 2017 / Notices 37595 

Individuals or organizations that wish 

to make a 5-minute oral presentation on 

an agenda topic should submit a written 

copy of the oral presentation to the DFO 

at the address listed in the ADDRESSES

section of this notice by the date listed 

in the DATES section of this notice. The 

number of oral presentations may be 

limited by the time available. 

Individuals not wishing to make an oral 

presentation may submit written 

comments to the DFO at the address 

listed in the ADDRESSES section of this 

notice by the date listed in the DATES

section of this notice. 

III. Security and Building 

The meeting is open to the public, but 

attendance is limited to the space 

available. Persons wishing to attend this 

meeting must register by contacting the 

DFO at the address listed in the 

ADDRESSES section of this notice or by 

telephone at the number listed in the 

FOR FURTHER INFORMATION CONTACT

section of this notice by the date 

specified in the DATES section of this 

notice. 

Since this meeting will be held in a 

Federal Government Building, the 

Hubert H. Humphrey Building, Federal 

security measures are applicable. In 

planning your arrival time, we 

recommend allowing additional time to 

clear security. To gain access to the 

building, participants will be required 

to show a government-issued photo 

identification (for example, driver’s 

license or passport), and must be listed 

on an approved security list before 

persons are permitted entrance. Persons 

not registered in advance will not be 

permitted into the Hubert H. Humphrey 

Building and will not be permitted to 

attend the Panel meeting. 

All persons entering the building 

must pass through a metal detector. In 

addition, all items brought to the Hubert 

H. Humphrey Building, whether 

personal or for the purpose of 

presentation, are subject to inspection. 

We cannot assume responsibility for 

coordinating the receipt, transfer, 

transport, storage, set-up, safety, or 

timely arrival of any personal 

belongings or items used for the purpose 

of presentation. 

Authority: 42 U.S.C. 217a, sec. 222 of the 

Public Health Service Act, as amended; 42 

U.S.C. 1314(f), sec. 1114(f) of the Social 

Security Act; and Public Law 92–463, as 

amended (5 U.S.C. App. 2). 

Dated: August 2, 2017. 

Seema Verma, 

Administrator, Centers for Medicare & 

Medicaid Services. 

[FR Doc. 2017–16979 Filed 8–10–17; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Macula 

Degenerative Diseases 

Date: August 23, 2017. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Nataliya Gordiyenko, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5202, 

MSC 7846, Bethesda, MD 20892, 

301.435.1265, gordiyenkon@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 7, 2017. 

Sylvia L. Neal, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–16914 Filed 8–10–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Muscular Dystrophy 

Coordinating Committee (MDCC). 

The meeting will be open to the 

public and accessible by live webcast. 

Attendance is limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

Name of Committee: Muscular Dystrophy 

Coordinating Committee. 

Type of meeting: Open Meeting. 

Date: October 4, 2017. 

Time: 8:30 a.m. to 4:30 p.m. *Eastern 

Time*—Approximate end time. 

Agenda: Agenda: The purpose of this 

meeting is to bring together committee 

members, representing government agencies, 

patient advocacy groups, other voluntary 

health organizations, and patients and their 

families to update one another on progress 

relevant to the Action Plan for the Muscular 

Dystrophies and to coordinate activities and 

discuss gaps and opportunities leading to 

better understanding of the muscular 

dystrophies, advances in treatments, and 

improvements in patients’ and their families’ 

lives. Prior to the meeting, an agenda will be 

posted to the MDCC meeting registration Web 

site: https://meetings.ninds.nih.gov/ 

meetings/Oct42017/. 

Registration: To register, please go to: 

https://meetings.ninds.nih.gov/meetings/ 

Oct42017/. 

Webcast Live: For those not able to attend 

in person, this meeting will be webcast at: 

http://videocast.nih.gov/. 

Place: Neuroscience Center, Conference 

Room C/D, 6001 Executive Boulevard, 

Rockville, Maryland 20852. 

Contact Person: Glen H. Nuckolls, Ph.D., 

Executive Secretary, Muscular Dystrophy 

Coordinating Committee, National Institute 

of Neurological Disorders and Stroke, NIH, 

6001 Executive Boulevard, NSC 2203, 

Bethesda, MD 20892, (301) 496–5745, 

glen.nuckolls@ninds.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

All visitors must go through a security 

check at the building entrance to receive a 

visitor’s badge. A government issued photo 

ID is required. Further information can be 

found at the registration Web site: https://

meetings.ninds.nih.gov/meetings/Oct42017/. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 


asabaliauskas on DSKBBXCHB2PROD with NOTICES